Hygiene compliance remains the most cited challenge in orthodontic practice. The solution isn't asking patients to try harder — it's integrating biofilm control into the treatment protocol itself.
The Problem Orthodontists Know Too Well
Biofilm is the hidden driver of complications in aligner therapy. Despite careful treatment planning, uncontrolled biofilm leads to white spot lesions, gingival inflammation, attachment discoloration, and cloudy aligners — outcomes that undermine even the most precise clinical work.
The data confirms what every orthodontist sees chairside:
-
Up to 50% of orthodontic patients develop white spot lesions during treatment
-
Patients who develop enamel damage report dissatisfaction with their results — regardless of alignment quality
-
Fear of damaging teeth remains one of the most common reasons patients hesitate to begin orthodontic treatment
Traditional advice — "brush more carefully" — has never been a reliable solution. The issue is not patient motivation alone. It is the absence of a biofilm control strategy designed for the specific challenges of orthodontic therapy.
Why Conventional Products Fall Short
Aligners create conditions that favor biofilm accumulation. Salivary flow is reduced. Food particles are retained longer. Confined spaces around attachments become difficult to clean effectively.
Conventional oral care products were not designed for this clinical reality. Antiseptic mouthwashes disrupt the oral microbiome indiscriminately. High-abrasion formulas risk damaging aligner surfaces and enamel. Standard fluoride toothpastes do not address the specific biofilm dynamics that orthodontic appliances introduce.
The compliance gap is, in part, a product gap.
A Protocol-Driven Approach to Biofilm Control
The most effective way to improve hygiene compliance is to stop treating it as the patient's separate responsibility — and start treating biofilm management as an integrated clinical protocol.
The PRAEVA Biofilm Pro Care Protocol offers a structured, 5-step framework designed to do exactly that:
1. Biofilm Mapping. Chairside assessment using disclosing agents reveals invisible biofilm risk at the outset of treatment — before complications emerge.
2. Prescribe and Educate. The clinician prescribes a biofilm prevention protocol, framing daily care as a continuation of treatment. This positions the patient as a partner in their outcome, not a passive participant.
3. The Biofilm Routine. A simplified, consistent daily routine: brush teeth and aligners with PRAEVA Equiome™ Balance Toothpaste twice daily. Spit without rinsing to maintain the protective barrier. Rinse aligners separately. One product. One routine. For teeth and aligners alike.
4. In-Office Biofilm Therapy. Professional biofilm disruption — ideally through Guided Biofilm Therapy (GBT) — establishes a clean baseline and reinforces the value of at-home care through visible results.
5. Follow-Up and Track. The Praeva Progress Score (0–10) measures gum condition, plaque visibility, enamel quality, attachment appearance, and patient-reported adherence — transforming follow-up into a measurable, motivating metric.
The Mechanism: Selective Enzyme Targeting
At the core of this protocol is EquiomeTM, a biotechnology-derived Free Fatty Acid Complex of over 10 purified fatty acids concentrated more than 300× compared to their source oils.
EquiomeTM supports biofilm control without disrupting the oral microbiome. Rather than an antiseptic approach, it targets the glucosyltransferase (GTF) enzymes that microorganisms use to build biofilm matrix and produce acid. Biofilm formation is addressed at its enzymatic source. Beneficial bacteria remain undisturbed. Microbiome balance is preserved.
This selective mechanism is reinforced by:
-
Medical-grade nanohydroxyapatite — contributes to enamel remineralization and helps reduce sensitivity, supporting white spot lesion prevention
-
Polyphosphates — help prevent surface discoloration from coffee, tea, and wine, keeping teeth and aligners clear
-
A prebiotic system (xylitol, erythritol, inulin) — supports beneficial bacterial populations and contributes to lasting fresh breath
Studies confirm that PRAEVA Equiome™ Balance does not affect the surface morphology of orthodontic aligners or adhesives — an important consideration when selecting daily-use products for orthodontic patients.
Outcomes That Support the Protocol
When integrated into clinical workflows, this protocol contributes to measurable improvements:
-
Reduced visible biofilm on aligners within two weeks
-
Fewer white spot lesions during treatment
-
Improved patient-reported compliance and satisfaction
-
Cleaner attachments and healthier gingival tissues at follow-up
For clinicians, this translates to more predictable treatment outcomes, fewer complications, smoother workflows, and stronger patient loyalty. For patients, it means cleaner teeth, protected results, and confidence in their smile.
From Frustration to Framework
The orthodontic hygiene compliance challenge will not resolve itself. Aligners will continue to create favorable conditions for biofilm. Patients will continue to underestimate the risk.
The answer is precision prevention — a protocol that embeds biofilm control into every stage of treatment, supported by a product engineered specifically for this clinical need.
Safeguarding treatment success starts with the daily routine.
